Rituximab Use and Hypogammaglobulinemia

BACKGROUND Rituximab is a genetically engineered chimeric (murine-human) monoclonal antibody (mAb) directed against CD20 antigen on the surface of B cells. Commonly reported adverse effects are chills and fevers, which are usually associated with the first infusion. Recent studies have shown an asso...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The American journal of case reports 2020-04, Vol.21, p.e920681-e920681
Hauptverfasser:	Alhassan, Eaman, Johnson, Justina, Nakity, Rasha, Shah, Hajra Zehra
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!